At the news
? BULLISHIMPACT 7/10 425 filed May 7, 2026 at 09:01 ET
Penumbra shareholders voted overwhelmingly to approve the merger with Boston Scientific, with 99.7% of votes cast in favor. The deal now awaits remaining regulatory clearances (HSR and foreign antitrust) and is expected to close in the second half of 2026.
- 28,564,786 votes FOR the merger (99.7% of cast votes), 85,334 AGAINST, 15,813 abstentions
- 28,665,933 shares present or proxy out of 39,324,084 outstanding (72.9% quorum)
- Advisory compensation proposal also approved (27,811,605 FOR)
- Merger agreement dated January 14, 2026; Penumbra to survive as wholly owned subsidiary of Boston Scientific
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access